Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F16IL2 and doxorubicin in advanced solid tumors and breast cancer
NCT01131364Phase 2Terminated
- Sponsor
- Philogen
- Start
- Jun 2008
- Primary completion
- Mar 2012
- Modality
- Antibody Fragments, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of teleukin in solid tumor (advanced stage), breast cancer, sponsored by Philogen. Started Jun 2008; status: terminated.
02
Drugs
teleukin
03
Conditions
solid tumor (advanced stage)breast cancer
Beyond the preview
Go deeper on NCT01131364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131364.